491 related articles for article (PubMed ID: 18035585)
21. Suppressor of cytokine signaling-1 reduces high glucose-induced TGF-beta1 and fibronectin synthesis in human mesangial cells.
Shi Y; Zhang Y; Wang C; Du C; Zhao S; Qi Z; Zhang Q; Duan H
FEBS Lett; 2008 Oct; 582(23-24):3484-8. PubMed ID: 18801363
[TBL] [Abstract][Full Text] [Related]
22. Troglitazone inhibits synthesis of transforming growth factor-beta1 and reduces matrix production in human peritoneal mesothelial cells.
Peng Y; Liu H; Liu F; Liu Y; Li J; Chen X
Nephrology (Carlton); 2006 Dec; 11(6):516-23. PubMed ID: 17199790
[TBL] [Abstract][Full Text] [Related]
23. Anti-inflammatory effects of PPAR-gamma agonists directly correlate with PPAR-gamma expression during acute pancreatitis.
Rollins MD; Sudarshan S; Firpo MA; Etherington BH; Hart BJ; Jackson HH; Jackson JD; Emerson LL; Yang DT; Mulvihill SJ; Glasgow RE
J Gastrointest Surg; 2006; 10(8):1120-30. PubMed ID: 16966031
[TBL] [Abstract][Full Text] [Related]
24. Vascular inflammation is negatively autoregulated by interaction between CCAAT/enhancer-binding protein-delta and peroxisome proliferator-activated receptor-gamma.
Takata Y; Kitami Y; Yang ZH; Nakamura M; Okura T; Hiwada K
Circ Res; 2002 Sep; 91(5):427-33. PubMed ID: 12215492
[TBL] [Abstract][Full Text] [Related]
25. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits IL-1beta-induced cyclooxygenase-2 expression in mesangial cells.
Sawano H; Haneda M; Sugimoto T; Inoki K; Koya D; Kikkawa R
Kidney Int; 2002 Jun; 61(6):1957-67. PubMed ID: 12028436
[TBL] [Abstract][Full Text] [Related]
26. SOCS3 promotes inflammation and apoptosis via inhibiting JAK2/STAT3 signaling pathway in 3T3-L1 adipocyte.
Liu Z; Gan L; Zhou Z; Jin W; Sun C
Immunobiology; 2015 Aug; 220(8):947-53. PubMed ID: 25720636
[TBL] [Abstract][Full Text] [Related]
27. Differential modulation of COX-2 expression in A549 airway epithelial cells by structurally distinct PPAR(gamma) agonists: evidence for disparate functional effects which are independent of NF-(kappa)B and PPAR(gamma).
Patel KM; Wright KL; Whittaker P; Chakravarty P; Watson ML; Ward SG
Cell Signal; 2005 Sep; 17(9):1098-110. PubMed ID: 15993751
[TBL] [Abstract][Full Text] [Related]
28. PPAR-gamma agonists inhibit TGF-beta1-induced chemokine expression in human tubular epithelial cells.
Wang WM; Zhang HD; Jin YM; Zhu BB; Chen N
Acta Pharmacol Sin; 2009 Jan; 30(1):107-12. PubMed ID: 19098936
[TBL] [Abstract][Full Text] [Related]
29. Expression of STAT3 and SOCS3 in pancreatic acinar cells.
Vona-Davis LC; Frankenberry KA; Waheed U; Peterson E; McFadden DW
J Surg Res; 2005 Jul; 127(1):14-20. PubMed ID: 15893771
[TBL] [Abstract][Full Text] [Related]
30. Troglitazone and 15-deoxy-delta(12,14)-prostaglandin J2 inhibit shear-induced coupling factor 6 release in endothelial cells.
Tomita H; Osanai T; Toki T; Sasaki S; Maeda N; Murakami R; Magota K; Yasujima M; Okumura K
Cardiovasc Res; 2005 Jul; 67(1):134-41. PubMed ID: 15949477
[TBL] [Abstract][Full Text] [Related]
31. Diverse cardioprotective signaling mechanisms of peroxisome proliferator-activated receptor-gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone, in reperfusion injury: role of nuclear factor-kappaB, heat shock factor 1, and Akt.
Zingarelli B; Hake PW; Mangeshkar P; O'Connor M; Burroughs TJ; Piraino G; Denenberg A; Wong HR
Shock; 2007 Nov; 28(5):554-63. PubMed ID: 17589386
[TBL] [Abstract][Full Text] [Related]
32. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist inhibits transforming growth factor-beta1 and matrix production in human dermal fibroblasts.
Zhang GY; Cheng T; Zheng MH; Yi CG; Pan H; Li ZJ; Chen XL; Yu Q; Jiang LF; Zhou FY; Li XY; Yang JQ; Chu TG; Gao WY
J Plast Reconstr Aesthet Surg; 2010 Jul; 63(7):1209-16. PubMed ID: 19617014
[TBL] [Abstract][Full Text] [Related]
33. Regulatory effect of calcineurin inhibitor, tacrolimus, on IL-6/sIL-6R-mediated RANKL expression through JAK2-STAT3-SOCS3 signaling pathway in fibroblast-like synoviocytes.
Choe JY; Park KY; Park SH; Lee SI; Kim SK
Arthritis Res Ther; 2013 Feb; 15(1):R26. PubMed ID: 23406906
[TBL] [Abstract][Full Text] [Related]
34. TGF-β dampens IL-6 signaling in articular chondrocytes by decreasing IL-6 receptor expression.
Wiegertjes R; van Caam A; van Beuningen H; Koenders M; van Lent P; van der Kraan P; van de Loo F; Blaney Davidson E
Osteoarthritis Cartilage; 2019 Aug; 27(8):1197-1207. PubMed ID: 31054955
[TBL] [Abstract][Full Text] [Related]
35. Aspirin-triggered Lipoxin A4 attenuates mechanical allodynia in association with inhibiting spinal JAK2/STAT3 signaling in neuropathic pain in rats.
Wang ZF; Li Q; Liu SB; Mi WL; Hu S; Zhao J; Tian Y; Mao-Ying QL; Jiang JW; Ma HJ; Wang YQ; Wu GC
Neuroscience; 2014 Jul; 273():65-78. PubMed ID: 24836854
[TBL] [Abstract][Full Text] [Related]
36. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
[TBL] [Abstract][Full Text] [Related]
37. [Effects of fluvastatin on the expression of Janus kinase 2/signal transducers and activators of transcription (JAK/STAT) in glomerular mesangial cells under high concentration of glucose].
Shi YH; Zhao S; Ren YZ; Liu QJ; Duan HJ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Jul; 20(7):422-5. PubMed ID: 18611343
[TBL] [Abstract][Full Text] [Related]
38. Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis.
Ortiz-Muñoz G; Martin-Ventura JL; Hernandez-Vargas P; Mallavia B; Lopez-Parra V; Lopez-Franco O; Muñoz-Garcia B; Fernandez-Vizarra P; Ortega L; Egido J; Gomez-Guerrero C
Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):525-31. PubMed ID: 19164812
[TBL] [Abstract][Full Text] [Related]
39. Activation of peroxisome proliferator-activated receptor-gamma protects pancreatic beta-cells from cytokine-induced cytotoxicity via NF kappaB pathway.
Kim EK; Kwon KB; Koo BS; Han MJ; Song MY; Song EK; Han MK; Park JW; Ryu DG; Park BH
Int J Biochem Cell Biol; 2007; 39(6):1260-75. PubMed ID: 17521952
[TBL] [Abstract][Full Text] [Related]
40. The antagonist of the JAK-1/STAT-1 signaling pathway improves the severity of cerulein-stimulated pancreatic injury via inhibition of NF-κB activity.
Chen P; Huang L; Zhang Y; Qiao M; Yao W; Yuan Y
Int J Mol Med; 2011 May; 27(5):731-8. PubMed ID: 21369693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
